News

EpiBlok Therapeutics GmbH is developing a gene therapy for epilepsy

Read more

Dr. Angelika Vlachou, Principal at High-Tech Gründerfonds (HTGF), supported 25 translational SPARK project teams with a dedicated hands-on Pitch Training Workshop.

Read more

SPARK-BIH and NeuroCure organized a second Design Thinking workshop.

Read more

After the successful implementation of the NeuroCure/SPARK program, NeuroCure and SPARK-BIH prolong their collaboration and will run a second call for projects.

Read more

Researchers led by our SPARKee Ulrike Stein of the ECRC and Robert Preißner of Charité report in "Clinical and Translational Medicine" that statins inhibit a gene that promotes cancer cell metastasis.

Read more

NeuroCure grants funding extension to the four NeuroCure/SPARK-BIH teams for an additional year.

Read more

Our SPARKees Simone Spuler und Verena Schöwel present their startup MyoPax in Frank Thelen's Podcast Startup-DNA.

Read more

The Charité Spin-off BODYCLOCK Technologies by Prof. Dr. Achim Kramer developed a diagnostic assay to assess the circadian clock. The project has previously been supported by SPARK-BIH and BIH Digital Health Accelerator.

Read more

Two SPARK-BIH funded teams network with investors and the life science industry at the international JPM BIO Partnering Event.

Read more

SPARK Europe has joint forces for education on translational research and technology transfer! For the third time, European SPARK sites will host a joint webinar series during spring 2022.

Read more

SPARK-BIH is a member of the SPARK Global network